EFRELand Brandenburgbe Berlin
Innovation Forum Senftenberg
BIO 2016

About the Healthcare Industries Cluster

The Berlin-Brandenburg region is one of the leading life sciences and healthcare industries centers in the world. The region’s main strengths are its unique concentration of science, clinics and business and the close network they maintain. Numerous technology parks and networks in different fields, above all biotechnology and medical technology, create an ideal infrastructure for transforming the latest scientific findings into innovative products for the healthcare sector. The systematic innovation policy under the joint innovation strategy of the states Berlin and Brandenburg (innoBB) aims to expand the cluster's development and drive top performance for the regional and global healthcare markets.

The cluster managers welcome you to the HealthCapital cluster website!

Biotechnology and Pharmaceuticals

With cutting-edge research and development from molecules to products, biotechnology in the capital region provides an excellent environment for global players in the pharmaceuticals industry and top scientists.

Find out more about this focal area here.

Medical Technology

World leaders in medical technology – many of the over 300 medical technology companies in Berlin-Brandenburg can claim this title. They benefit from the close network between science, business and clinics here.

Find out more about this focal area here.

Innovative Patient Care & Rehabilitation

For medical care and rehabilitation or nursing care – in the capital region, patients of all ages will benefit from capable, highly networked medical care at the highest level.

Find out more about this focal area here.


Health Tourism & Prevention

Berlin-Brandenburg is one of the most attractive healthcare regions with an international flair. It provides lots of space and a wide range of services for prevention, medical tourism and wellness.

Find out more about this focal area here.

 

News

26.05.2016

SCIENION inks Joint Development and Marketing pact with AXELA

Berlin, Germany, and Toronto, Canada, MAY 24, 2016: SCIENION AG, a developer of a revolutionary new ultra-low volume liquid handling technology, is pleased to announce that it has entered into a strategic, joint development... ► Read more ...

18.05.2016

ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics

Afucosylation can enable more precise assessment of allergic sensitization ► Read more ...

13.05.2016

Humedics submits marketing authorization application for the diagnostic agent used with the LiMAx test

Application for marketing authorization of the diagnostic agent 13C-Methacetin Solution for infusion used with the LiMAx test ► Read more ...

Events

no news in this list.